SDF-1 is an antifibrotic mediator in vivo
A. Gazdhar (Bern, Switzerland), K. Fytianos (Bern, Switzerland), R. Schliep (Bern, Switzerland), S. Mykoniati ( Delemont,, Switzerland), P. Khan (Basel, Switzerland), K. Hostettler (Basel, Switzerland), L. Knudsen (Hanover , Germany), T. Geiser (Hanover, Germany)
Source: Virtual Congress 2020 – Translational therapeutic advances
Session: Translational therapeutic advances
Session type: E-poster session
Number: 3357
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Gazdhar (Bern, Switzerland), K. Fytianos (Bern, Switzerland), R. Schliep (Bern, Switzerland), S. Mykoniati ( Delemont,, Switzerland), P. Khan (Basel, Switzerland), K. Hostettler (Basel, Switzerland), L. Knudsen (Hanover , Germany), T. Geiser (Hanover, Germany). SDF-1 is an antifibrotic mediator in vivo. 3357
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Inhibitory effect of statins on fibrogenic mediator production from lung cells Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012
Nintedanib mediates effective modulation of relevant pro-fibrotic biomarkers ex vivo Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin Year: 2019
A decoy CXCL8 with increased glycosaminoglycan binding has potent anti-inflammatory activity in lung inflammation models Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010
Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE2 Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010
Dimethylfumarate reduces growth factor- and cytokine-induced IL-6 release from human lung fibroblasts: role of (NF)-κB Source: Annual Congress 2008 - Airway cell biology and immunology Year: 2008
RB2/p130 gene-enhanced expression downregulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo Source: Eur Respir J 2002; 20: Suppl. 38, 3s Year: 2002
Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases Year: 2018
Inhibition of VEGF and MMP-9 production by Pregabalin in human immunocompetent cells in vitro Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
Human Airway Trypsin-like protease exerts potent anti-fibrotic role in vivo. Source: International Congress 2017 – Rare diseases Year: 2017
Profibrotic cytokine TGF-β1 increases endothelial progenitor cell angiogenic properties Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012
The PDE4-inhibitors roflumilast and rolipram modulate fibroblast collagen-gel contraction and chemotaxis mediated by autocrine PGE2 synthesis induced by TGF-β1 Source: Eur Respir J 2005; 26: Suppl. 49, 214s Year: 2005
The effect of recombinant Il-8 on eosinophil migration in vitro and in vivo Source: Eur Respir J 2002; 20: Suppl. 38, 382s Year: 2002
In vitro profibrotic effects of rapamycin on basal or TGF-β1 induced primary human lung fibroblast: ECM production and turnover, migration and differentiation Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012
Selective inhibition of COX-2 by celecoxib exerts negative effects on endothelial progenitor cell proliferation and stimulates apoptosis in vitro Source: Eur Respir J 2005; 26: Suppl. 49, 368s Year: 2005
Inhibition of chloride channel activity by BMP-2 in lung fibroblasts opposes profibrotic action of endothelin-1 Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010
Statins suppress LPS-induced proinflammatory cytokine production from human bronchial epithelial cells Source: Annual Congress 2009 - Epithelial cell biology Year: 2009
The GLP-1 receptor agonist Liraglutide attenuates intermittent hypoxia-induced pro-inflammatory macrophage polarization in primary macrophages Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing Year: 2021
Adapalene abrogates erlotinib-induced skin disorder by regulating proinflammatory cytokine production from human epidermal cells Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
The anti-inflammatory effects of angiopoietin-1 in mice asthma Source: Eur Respir J 2007; 30: Suppl. 51, 680s Year: 2007
Role of transient receptor potential vanilloid 4 in the therapeutic antifibrotic effects of pirfenidone Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019